A T Reddy
Affiliation: University of Alabama at Birmingham
- Chemotherapy for low-grade gliomasA T Reddy
Department of Pediatric Neurology, The Children s Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL 35233, USA
Childs Nerv Syst 15:506-13. 1999..This chapter reviews the published chemotherapeutic trials. Chemotherapy appears to have a major role in the management of children with progressive low-grade gliomas...
- MedulloblastomaA T Reddy
Division of Pediatric Neurology, The Children s Hospital of Alabama, University of Alabama at Birmingham, USA
Curr Opin Neurol 12:681-5. 1999..Current laboratory investigations are shedding light on the oncogenesis of medulloblastoma and may lead to improved treatments...
- Advances in biology and treatment of childhood brain tumorsA T Reddy
Departments of Pediatrics and Neurology, University of Alabama at Birmingham, Children s Hospital of Alabama, 1600 7th Ave South, Suite 516 ACC, Birmingham, AL 35233, USA
Curr Neurol Neurosci Rep 1:137-43. 2001..A growing body of work is aimed at improving the outcome for children with brain tumors not only through clinical trials, but also by focusing on the biologic underpinning of these diseases that have been poorly understood...
- Neurologic complications of chemotherapy for children with cancerAlyssa T Reddy
The Children s Hospital of Alabama, 1600 7th Avenue South, Suite 512 ACC, Birmingham, AL 35233, USA
Curr Neurol Neurosci Rep 3:137-42. 2003..Such investigation is greatly needed, as it may lead to a better understanding of how chemotherapy affects the nervous system and ultimately help develop more strategies to prevent drug-related neurotoxicity in pediatric cancer patients...
- Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidusAlyssa T Reddy
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA
Neuro Oncol 6:127-33. 2004..Patients should be evaluated for DI as part of the initial staging, and if it is present, the patients should be treated for suprasellar disease regardless of MRI findings...
- Atypical teratoid/rhabdoid tumors of the central nervous systemAlyssa T Reddy
University of Alabama at Birmingham, Birmingham, AL 35233, USA
J Neurooncol 75:309-13. 2005..The function of the gene is not yet understood. Prospective clinical and biologic trials are greatly needed to understand the efficacy of therapeutic interventions, as well as the role of the gene...
- Neuroendoscopic findings in patients with intracranial germinomas correlating with diabetes insipidusJohn C Wellons
Section of Pediatric Neurosurgery, and Divisions of Pediatric Hematology/Oncology and Pediatric Endocrinology, Children's Hospital, Birmingham, Alabama 35233, USA
J Neurosurg 100:430-6. 2004....
- Ophthalmologic involvement in the syndrome of headache, neurologic deficits, and cerebrospinal fluid lymphocytosisDavid G Morrison
Department of Ophthalmology, University of Alabama School of Medicine, Birmingham, Alabama, USA
Ophthalmology 110:115-8. 2003..As in other disorders causing papilledema, these patients may have permanent visual sequelae. Recognition by the ophthalmologist of this rarely reported syndrome will facilitate prompt patient diagnosis and treatment...
- A pilot trial comparing cerebral perfusion pressure-targeted therapy to intracranial pressure-targeted therapy in children with severe traumatic brain injuryPriya Prabhakaran
Departments of Pediatrics and Surgery, University of Alabama at Birmingham, Alabama, USA
J Neurosurg 100:454-9. 2004..08). CONCLUSIONS: The CPP method appears to be safe, although this feasibility study does not establish that the CPP therapy is superior to ICP therapy...